Your browser doesn't support javascript.
loading
Two Cases of Macular Edema Associated with Extramacular Branch Retinal Vein Occlusion
Journal of the Korean Ophthalmological Society ; : 330-333, 2016.
Article in Korean | WPRIM | ID: wpr-102331
ABSTRACT

PURPOSE:

To report two cases of patients treated for macular edema associated with extramacular branch retinal vein occlusion (BRVO). CASE

SUMMARY:

(Case 1) A 64-year-old female presented with macular edema (ME) associated with superotemporal extra-macular BRVO. The ME was resolved but hard exudate (HE) deposited after combined therapy of intravitreal bevacizumab injection and laser photocoagulation of the BRVO area. Best corrected visual acuity (BCVA) improved from 0.2 to 0.5 following absorption of HE. (Case 2) A 53-year-old male presented with ME associated with extramacular BRVO outside the superior vascular arcade. ME was treated with 2 monthly injections of bevacizumab and laser photocoagulation in the BRVO area. Although HE deposited after resolution of ME, it was absorbed and BCVA improved from 0.1 to 0.4. The ME did not recur in either patient.

CONCLUSIONS:

We report 2 cases managed with combined therapy of intravitreal bevacizumab injection and laser photocoagulation for ME associated with extramacular BRVO.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Retinal Vein / Retinaldehyde / Retinal Vein Occlusion / Visual Acuity / Macular Edema / Absorption / Exudates and Transudates / Bevacizumab / Light Coagulation Limits: Female / Humans / Male Language: Korean Journal: Journal of the Korean Ophthalmological Society Year: 2016 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Retinal Vein / Retinaldehyde / Retinal Vein Occlusion / Visual Acuity / Macular Edema / Absorption / Exudates and Transudates / Bevacizumab / Light Coagulation Limits: Female / Humans / Male Language: Korean Journal: Journal of the Korean Ophthalmological Society Year: 2016 Type: Article